Philochem(瑞士)

Philochem

瑞士Philochemwww.philogen.comPhilogen成立于1996年,在瑞士與意大利的生物技術公司.Philogen的重點是生物制藥的新血管生成有關的疾病的治療發展。血管生成，即新血管的形成，是一個如癌癥，類風濕關節炎，老年性黃斑變性的許多嚴重病癥的特征。PhilogenisaSwiss-Italianintegratedbiotechnologycompanyfoundedin 1996bythebrothersDario,Duccio,GiovanniNeri,withtheinitialmissiontodevelopasproductsthepromisinghumanantibodiesdiscoveredbyProf.DarioNeri.Philogenfocusesonthedevelopmentofnewbiopharmaceuticalsforthetreatmentofangiogenesis-relateddisorders.Angiogenesis,i.e.theformationofnewbloodvessels,isacharacteristicfeatureofmanyseverepathologiessuchascancer,rheumatoidarthritisandage-relatedmaculardegeneration.Thecompanyhasbeenapioneerintheisolation,engineeringandclinicaldevelopmentofleadproductscapableoftargetingangiogenesisin-vivoandhasbeenthefirstintheworldtodemonstratethathumanmonoclonalantibodies,specificforamarkerofangiogenesis,canefficiently